Tilray Brands Inc TLRY

Morningstar Rating
CA$5.13 +0.05 (0.98%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TLRY is trading at a LOCK|m%PXth premium.
Price
CA$5.08
Fair Value
LOCK|.^<tWD$q
Uncertainty
LOCK|?? f!@Cr
1-Star Price
LOCK|.yV>#
5-Star Price
LOCK|%dct#b
Economic Moat
LOCK|%R#
Capital Allocation
LOCK|tM@d@J

News

Trading Information

Previous Close Price
CA$5.08
Day Range
CA$5.06–5.19
52-Week Range
CA$5.04–32.30
Bid/Ask
CA$5.09 / CA$5.15
Shares Outstanding
147.78M
Market Cap
CA$758.12M
Volume/Avg
893,529 / 549,014

Key Statistics

Price/Earnings (Normalized)
10.62
Price/Sales
0.45
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
3,595

Valuation

Metric
TLRY
Price/Earnings (Normalized)
10.62
Price/Book Value
0.30
Price/Sales
0.45
Price/Cash Flow
22.61
Price/Earnings
TLRY

Financial Strength

Metric
TLRY
Quick Ratio
1.17
Current Ratio
2.21
Interest Coverage
−2.15
Quick Ratio
TLRY

Profitability

Metric
TLRY
Return on Assets (Normalized)
0.57%
Return on Equity (Normalized)
0.78%
Return on Invested Capital (Normalized)
1.65%
Return on Assets
TLRY

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|xMlg<&?LOCK|NqW#$66B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|%!CNsJSLOCK|BjD?B$46B
Haleon PLC ADR
HLN
LOCK|@hbWm<WLOCK|M>$38B
Zoetis Inc Class A
ZTS
LOCK|$@LJHR>LOCK|L>$29B
Viatris Inc
VTRS
LOCK|Wn<j@>LOCK|rG$20B
Elanco Animal Health Inc
ELAN
LOCK|H#LOCK|$d$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|%q&Kb%KLOCK|>L%$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|dfD^j$?LOCK|?L$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|@^b??yYLOCK|jQ#L@$2B
Perrigo Co PLC
PRGO
LOCK|cwYDKqLOCK|n^y$2B

Sponsor Center